Advanced test for fetal abnormalities too costly for most women

By Craig Butt
Updated July 31 2015 - 10:08am, first published July 20 2015 - 12:15am
Erin Mullins Grech opted to undergo the subsidised maternal serum screening in order to be as informed as possible about her pregnancy. Photo: Arsineh Houspian
Erin Mullins Grech opted to undergo the subsidised maternal serum screening in order to be as informed as possible about her pregnancy. Photo: Arsineh Houspian

A maternal blood test that determines fetal abnormalities early in pregnancy is too costly and should be made more widely available, a Medical Journal of Australia editorial argues.